# OnCo record saigenci-adelaide (institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/institutions/saigenci-adelaide/>
  a schema:MedicalOrganization ;
  onco:kind "institution" ;
  schema:identifier "saigenci-adelaide" ;
  schema:name "South Australian immunoGENomics Cancer Institute (SAiGENCI), University of Adelaide"@en ;
  schema:alternateName "SAiGENCI"@en, "University of Adelaide cancer institute"@en ;
  schema:description "Cancer research institute founded at the University of Adelaide in 2021 and directed by Christopher Sweeney, who led the CHAARTED trial that brought docetaxel into first-line treatment of metastatic prostate cancer."@en ;
  schema:url <https://onco.cc/institutions/saigenci-adelaide/> ;
  schema:dateModified "2026-09-18"^^xsd:date ;
  schema:addressCountry "AU" ;
  schema:addressLocality "Adelaide" ;
  schema:latitude "-34.921"^^xsd:decimal ;
  schema:longitude "138.606"^^xsd:decimal ;
  onco:cancers <https://onco.cc/cancers/prostate/> ;
  onco:institutions <https://onco.cc/institutions/royal-adelaide-hospital/> ;
  onco:people <https://onco.cc/people/christopher-sweeney/> .